Hellenic Dynamics (HELD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock HELD vs. HLN, BXP, HIK, HCM, INDV, AMYT, AGY, APH, ANCR, and VLGShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Animalcare Group (ANCR), and Venture Life Group (VLG). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. Its Competitors Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Alliance Pharma Animalcare Group Venture Life Group Hellenic Dynamics (LON:HELD) and Haleon (LON:HLN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends. Does the media favor HELD or HLN? In the previous week, Haleon had 4 more articles in the media than Hellenic Dynamics. MarketBeat recorded 4 mentions for Haleon and 0 mentions for Hellenic Dynamics. Hellenic Dynamics' average media sentiment score of 0.00 beat Haleon's score of -0.17 indicating that Hellenic Dynamics is being referred to more favorably in the media. Company Overall Sentiment Hellenic Dynamics Neutral Haleon Neutral Do analysts recommend HELD or HLN? Haleon has a consensus target price of GBX 435, indicating a potential upside of 21.27%. Given Haleon's stronger consensus rating and higher probable upside, analysts plainly believe Haleon is more favorable than Hellenic Dynamics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hellenic Dynamics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Haleon 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders believe in HELD or HLN? 0.1% of Hellenic Dynamics shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by company insiders. Comparatively, 10.7% of Haleon shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is HELD or HLN more profitable? Haleon has a net margin of 9.66% compared to Hellenic Dynamics' net margin of 0.00%. Haleon's return on equity of 6.54% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets Hellenic DynamicsN/A -364.21% N/A Haleon 9.66%6.54%4.45% Which has higher valuation and earnings, HELD or HLN? Haleon has higher revenue and earnings than Hellenic Dynamics. Hellenic Dynamics is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHellenic DynamicsN/AN/A-£5.22M-£3.55N/AHaleon£11.07B2.92£1.07B£11.8930.17 SummaryHaleon beats Hellenic Dynamics on 12 of the 14 factors compared between the two stocks. Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£14K£2.23B£5.61B£3.10BDividend YieldN/A2.92%4.61%5.04%P/E Ratio0.004.1330.29169.18Price / SalesN/A686.16470.61307,479.17Price / CashN/A10.3738.2127.94Price / BookN/A11.138.865.26Net Income-£5.22M£20.70B£3.25B£5.89B7 Day PerformanceN/A3.49%3.72%-0.01%1 Month PerformanceN/A6.29%5.86%0.74%1 Year PerformanceN/A3.23%30.49%62.68% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AN/AN/AN/A£14KN/A0.00N/AHLNHaleon1.3734 of 5 starsGBX 365.83+1.8%GBX 413.50+13.0%-4.3%£33.02B£11.07B30.7725,408BXPBeximco PharmaceuticalsN/AGBX 39flatN/A+40.7%£26.59B£7.08T4.185,500Gap UpHIKHikma Pharmaceuticals4.0315 of 5 starsGBX 1,934.03-1.5%GBX 2,560+32.4%-14.2%£5.36B£3.74B18.989,100Analyst ForecastGap DownHCMHUTCHMEDN/AGBX 264-3.5%N/A-20.0%£2.87B£771.01M-67.381,760Gap UpINDVIndivior2.481 of 5 starsGBX 1,238+1.6%GBX 1,650+33.3%+30.4%£1.93B£1.40B-1,026.481,000Gap UpHigh Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 8flatN/A+75.0%£393.21M£72.18M-7.71612Gap DownAPHAlliance Pharma2.1284 of 5 starsGBX 64.70flatGBX 6,250+9,560.0%N/A£350.32M£183.50M-10.4391,000ANCRAnimalcare GroupN/AGBX 268-1.5%N/A-4.8%£183.74M£84.90M5.00220VLGVenture Life GroupN/AGBX 61.25+2.1%N/A+27.1%£78.05M£51.77M103.94165High Trading Volume Related Companies and Tools Related Companies Haleon Competitors Beximco Pharmaceuticals Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Allergy Therapeutics Competitors Alliance Pharma Competitors Animalcare Group Competitors Venture Life Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HELD) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.